baber/WOPTO huggingface dataset:
Patent AU-684392-B2 (AU)
Title: 1,2,3,4-tetrahydroquinoxalindione derivative
Inventor: SHISHIKURA JUN-ICHI
IPC: C07D521/00
Filed: 1995-09-25
Granted: 1997-12-11
Abstract: A 1,2,3,4-tetrahydroquinoxalinedione derivative represented by the following formula (I) or salt thereof, an NMDA-glycine receptor and/or AMPA receptor antagonist or kainic acid neurotoxicity inhibitor containing the derivative or salt. In addition, a pharmaceutical composition comprising said compound and a pharmaceutically acceptable carrier. <CHEM> wherein symbols in the above formula represent the following meanings, respectively:     X: N, CH,   R: an imidazolyl group or a di-lower alkylamino group,   R<1>:   (1) a halogen atom, a nitro group, a cyano group, a carboxyl group, an amino group, a mono- or di-lower alkylamino group, a lower alkanoyl group, a lower alkylthio group, a lower alkylsulfinyl group, a lower alkylsulfonyl group or a carbamoyl group, (2) a lower alkyl group or lower alkoxyl group which may be substituted by a halogen atom, a carboxyl group or an aryl group, (3) a phenyloxy group which may be substituted by a lower alkoxycarbonyl group or a carboxyl group,   R<2>: a hydroxyl group, a lower alkoxyl group, an amino group or a mono- or di-lower alkylamino group, A: a lower alkylene group which may be substituted or a group represented by the formula -O-B-, and   B: a lower alkylene group, with the proviso that the case wherein R represents an imidazolyl group, R<1> represents a cyano group, A represents an ethylene group and R<2> represents a hydroxyl group is excluded.
Patent AU-784383-B2 (AU)
Title: Trade molecules and uses related thereto
Inventor: WOOD CLIVE
IPC: C12N5/09
Filed: 2001-02-09
Granted: 2006-03-23
Abstract: The present invention relates, at least in part, to methods of modulating proliferation and apoptotic state of cells using agents that modulate the expression and/or activity of TRADE family polypeptides. In addition, the invention provides two novel members of the TRADE family of molecules.
Patent AU-658496-B2 (AU)
Title: Gas and parting medium supply and distribution system for a device for continuous casting
Inventor: SCHNEIDER WOLFGANG
IPC: B22D11/07
Filed: 1993-04-13
Granted: 1995-04-13
Abstract: Apparatus for the continuous casting of metal while simultaneously supplying a lubricant (13) or a lubricant mixture to the surface of the cast strand, with delivery channels (30,36) for at least one lubricant or a lubricant mixture, the outlet openings of which emerge in an intermediate area between a hot top (21), through the opening of which molten metal is supplied, and a mould in the open cross-section of which the molten metal solififies. Provided between the hot top and the mould (22) is an intermediate element with a central opening, the surfaces of which, together with the adjoining surfaces of the hot top and/or of the mould, form at least the end sections of the delivery channels (30,36), which end sections lead directly to the outlet openings, the intermediate element being a sheet-metal part. In addition, end sections of the delivery channels, said end sections extending at least as far as the opening edge, are machined into the surface of the intermediate element and/or into the surface of the mould to a constant depth. <IMAGE>
Patent AU-765624-B2 (AU)
Title: Nonwoven fabric and method and apparatus for manufacturing same
Inventor: COLSON WENDELL B
IPC: D04H3/12
Filed: 2000-01-10
Granted: 2003-09-25
Abstract: An apparatus for fabricating a unique nonwoven fabric which has the appearance of a woven fabric includes a supply station for parallel warp yarns, a support structure for orienting the parallel warp yarns into a cylindrical orientation, a weft yarn applicator for wrapping weft yarns around the cylindrically oriented warp yarns after an adhesive scrim has been overlaid onto the warp yarns, a heating station for activating the adhesive and a cooling station for setting the adhesive, and a cutter for severing the cylindrically formed fabric laminate so that it can be flattened and wrapped onto a take-up roller. The weft yarn applicator including a rotating drum wherein a plurality of spools of weft yarn material are mounted in circumferentially spaced relationship and a tensioner is provided for applying the weft yarn material around the warp yarns in a predetermined tension which may be the same as, greater than, or less than the tension in the warp yarns.
Patent AU-784791-B2 (AU)
Title: Arrangement for clamping inner bearing race to non-circular section shaft and for preventing axial load in the bearing, axial creep and rotational knock
Inventor: BASS MERLYN DUANE
IPC: F16C35/063
Filed: 2002-05-01
Granted: 2006-06-22
Abstract: Each end of a rotating element (16) is defined by a stub shaft (22) is non-circular in cross section and supported from a side wall (12) for rotation by a ball bearing (26) having an inner race (28) containing a mounting hole that is shaped complementary to, and located on, the stub shaft (22). The inner race (28) is clamped from moving axially or radially relative to the shaft (22), thereby preventing the bearing (26) from knocking against the stub shaft (22) during operation.
Patent AU-581873-B2 (AU)
Title: Pressure modifying system
Inventor: BLUMENTHAL MICHAEL BERNARD
IPC: G05D16/06
Filed: 1985-02-07
Granted: 1989-03-09
Abstract: 57 A pressure modifying valve for anaesthetic gas scavenging systems for connection between a high vacuum source such as a hospital building service and the outlet from a patient or anaesthetic machine. The valve (100) comprises a housing (102, 104, 106) divided by a partition (108) into two chambers (110, 112) having inlet (114) and outlet (116) ports respectively. The partition (108) has a flow restricting orifice (118) controlled by a valve member (136) which is supported on a diaphragm (138) to be self adjusting In response to pressure in the chamber (112). On the patient side, the pressure in chamber (110) is controlled by pressure relief valves (120) which are similar and interchangeable. The valve is made inexpensively of plastics and is disposable before the plastics deteriorates or undesirable matter accumulates and affects the functioning of the valve.
Patent AU-662624-B2 (AU)
Title: Diazabicycloalkene derivatives
Inventor: MIMURA TETSUYA
IPC: A61K31/502
Filed: 1993-05-12
Granted: 1995-09-07
Abstract: A compound of formula (I) possesses excellent potassium channel opening activity and is effective on various diseases arising from contractions of blood vessels, bronchial smooth muscles, etc., for example, ischemic heart diseases exemplified by angina pectoris, asthma, pollakisuria, sequela of subarachnoid hemorrhage, peripheral arterioinfarct, and so on. The compound has potent and long-lasting antihypertensive activity, with the onset of the action being slow, excellent activity in increasing renal blood flow, and high safety, and is therefore particularly useful as an antihypertensive. <CHEM> The substituents are as defined in the specification.nel
Patent AU-574434-B2 (AU)
Title: Disinfectant composition of lauric acid polyol ester and esters of hydroxybenzoic acid
Inventor: KATO KENNETH HAYAMI
IPC: A01N37/40
Filed: 1985-02-26
Granted: 1988-07-07
Abstract: The present invention relates to the use of aqueous compositions at ambient temperatures to clean, disinfect and preserve contact lenses. It has been a problem that when prior aqueous compositions contain anti-microbial constituents at active concentrations, these constituents tend to be absorbed or concentrated by the lens (particularly soft contact lenses), resulting in damage to the lens or harm to the eye of the user.The present invention provides a composition that is active against a wide variety of microorganisms yet is compatible with soft contact lenses as well as non-irritating and safe for contact with the human eye.The composition includes glyceryl monolaurate in combination with one or more other anti-microbial agents, and optionally an organic surfactant, for use in a solution for cleaning, disinfecting and preserving contact lenses.
Patent AU-589567-B2 (AU)
Title: Novel N-hydroxyl protecting groups and process for the preparation of 3-acylamino-1-hydroxy-2-azetidinones
Inventor: MUELLER RICHARD HENRY
IPC: C07D417/12
Filed: 1985-07-25
Granted: 1989-10-19
Abstract: Disclosed are novel chemical compounds having the formula <CHEM> and processes for using compounds of formula I to obtain compounds having the formula <CHEM>
Patent AU-731850-B2 (AU)
Title: Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
Inventor: BERGERON MICHEL G
IPC: C12Q1/68
Filed: 1997-11-04
Granted: 2001-04-05
Abstract: DNA-based methods employing amplification primers or probes for detecting, identifying, and quantifying in a test sample DNA from (i) any bacterium, (ii) the species  Streptococcus agalactiae, Staphylococcus saprophyticus, Enterococcus faecium, Neisseria meningitidis, Listeria monocytogenes  and  Candida albicans,  and (iii) any species of the genera  Streptococcus, Staphylococcus, Enterococcus,  Neisseria and  Candida  are disclosed. DNA-based methods employing amplification primers or probes for detecting, identifying, and quantifying in a test sample antibiotic resistance genes selected from the group consisting of  bla tem , bla rob , bla shv , bla oxa , blaZ,  aadB,  aacC1,  aacC2, aacC3,  aacA4,  aac6'-IIa,  ermA, ermB, ermC, mecA, vanA, vanB, vanC, satA, aac(6)-aph(2"),  aad(6'),  vat, vga, msrA, sul  and  int  are also disclosed. The above microbial species, genera and resistance genes arc all clinically relevant and commonly encountered in a variety of clinical specimens. These DNA-based assays are rapid, accurate and can be used in clinical microbiology laboratories for routine diagnosis. These novel diagnostic tools should be useful to improve the speed and accuracy of diagnosis of microbial infections, thereby allowing more effective treatments. Diagnostic kits for (i) the universal detection and quantification of bacteria, and/or (ii) the detection, identification and quantification of the above-mentioned bacterial and fungal species and/or genera, and/or (iii) the detection, identification and quantification of the above-mentioned antibiotic resistance genes arc also claimed.
Patent AU-524694-B2 (AU)
Title: Adjustable lamp
Inventor: TERRY JOHN VICTOR
IPC: F21V21/26
Filed: 1979-07-17
Granted: 1982-09-30
Abstract: An adjustable lamp is provided (figure 1) comprising a main arm (12) which is pivoted to a base (10) at one end and carries the lamp housing (18) at the outher end. The angular position of the arm relative to the base is controlled by a link (24) also pivoted to the base and to a sliding connection (30) on the arm. There is adjustable frictional resistance to sliding, and additionally the link is spring urged to counterbalance the increasing turning moment as the arm moves towards the horizontal position.
Patent AU-531570-B2 (AU)
Title: Fabrics for papermaking machines
Inventor: MCDONALD ROBERT L
IPC: D03D1/00
Filed: 1979-08-02
Granted: 1983-09-01
Abstract: A fabric (10), adapted for use in a belt of a papermaking machine, is formed of interwoven machine direction warp (12) and cross-machine direction shute (14) type strands, at least the shute strands (14) being woven in a repetitive pattern of passing under at least three adjacent warp strands (12) and then passing over at least two adjacent warp strands (12) so as to form a <2>/3 type weave pattern.
Patent AU-621455-B2 (AU)
Title: Packaging tray
Inventor: SCHUSTER RICHARD LEE
IPC: B65D5/487
Filed: 1990-01-19
Granted: 1992-03-12
Abstract: A paperboard tray for holding spaced rows of flat articles. A divider separating the rows includes sloped walls which, along with sloped wall portions in the side panels of the tray, serve to support the articles. A web connecting an outer end flap to a divider wall acts as a stop member to automatically position the end of the inner end flap as the overlapping flaps are moved into position during the formation of the tray from a blank.
Patent AU-691742-B2 (AU)
Title: Fertilizer and process for production thereof
Inventor: FJELLDAL ERLING
IPC: C05F3/00
Filed: 1996-04-18
Granted: 1998-05-21
Abstract: PCT No. PCT/IB96/00346 Sec. 371 Date Dec. 31, 1997 Sec. 102(e) Date Dec. 31, 1997 PCT Filed Apr. 18, 1996 PCT Pub. No. WO96/33961 PCT Pub. Date Oct. 31, 1996A process for producing a fertilizer from an organic waste material is described which comprises treating a waste, having a water content of no more than 90% by weight and which has been alkalinized, with nitrogen dioxide or a precursor thereof in sufficient amount to reduce the pH by at least 2.0 pH units. The process produces an organic fertilizer in which the percentage by weight of nitrogen in the form of oxides of nitrogen is higher than percentage by weight of nitrogen in the form of ammonium ion.
Patent AU-617934-B2 (AU)
Title: Bread improvers
Inventor: MAAT JAN
IPC: A21D2/18
Filed: 1990-03-21
Granted: 1991-12-05
Abstract: Cellulase bread improvers e.g., xylanase include an oxidase or peroxidase. The mixture may be incorporated in flour as an additive to dough for bread or other baked dough products e.g. puff pastry.
Patent AU-620768-B2 (AU)
Title: Process for preparing chlorofluorocarbons via an in situ generated activated aluminum trihalide catalyst and products resulting therefrom
Inventor: ZAWALSKI ROBERT C
IPC: C07C19/12
Filed: 1990-03-29
Granted: 1992-02-20
Abstract: A process of isomerizing a chlorofluorocarbon of the formula:  CClFYCClFX wherein X and Y are independently selected from chlorine and fluorine provided that X is not -Cl when Y is -F  to the compound of the formula:  CCl2YCF2X The process comprises contacting the chloroflurocarbon with an activated aluminum trihalide catalyst. The catalyst is prepared by contacting the chlorofluorocarbon with anhydrous aluminum trichloride in the presence of a metal. The metal is selected from the group consisting of stainless steel, chromium, manganese, molybdenum, tungsten and combinations thereof.
Patent AU-730652-B2 (AU)
Title: Method for drying anhydrous paroxetine hydrochloride
Inventor: OKATAKE MITSURU
IPC: A61K31/445
Filed: 1999-04-12
Granted: 2001-03-08
Abstract: A process for drying paroxetine hydrochloride anhydrate comprising (A) reacting a paroxetine compound with hydrogen chloride in the presence of isopropyl alcohol and crystallizing the resulting product, to obtain paroxetine hydrochloride anhydrate, and drying the resulting paroxetine hydrochloride anhydrate at a temperature of not more than 60 DEG C and under normal pressure or lower in an atmosphere which does not substantially contain moisture until the content of isopropyl alcohol attains to not more than 15% by weight; and (B) further drying the paroxetine hydrochloride anhydrate at a temperature of 80 DEG  to 110 DEG C in an atmosphere reduced to not more than 20 mm Hg until the content of isopropyl alcohol attains to not more than 5% by weight. According to the present invention, the amount of remaining isopropyl alcohol contained in the paroxetine hydrochloride anhydrate, crystallized in the presence of isopropyl alcohol, can be efficiently reduced in a short period of time without necessitating a large-scaled apparatus.
Patent AU-599896-B2 (AU)
Title: A dry food product reconstitutable with cold or hot aqueous liquid and a process for making same
Inventor: GLITTENBERG DETLEV
IPC: A23L11/00
Filed: 1986-02-17
Granted: 1990-08-02
Abstract: A dry food product reconstitutable with cold or hot aqueous liquid to a pulpily structured fruit sauce, soup, juice, compote, concassée, savoury vegetable-containing soup or snack meal containing added starch and, optionally, further consistency - and/or structure-imparting components as well as at least one taste-and/or flavor imparting dry vegetable and/or fruit component (fruit substance), is characterized in that the added starch consists at least partially of cold-swelling leguminous pre-gelatinized starch.
Patent AU-719629-B2 (AU)
Title: Endothelium specific expression regulated by EPCR control elements
Inventor: ESMON CHARLES T
IPC: C07K14/74
Filed: 1997-11-07
Granted: 2000-05-11
Abstract: The promoter of the EPCR gene has been isolated from both murine (SEQ. ID No. 1) and human (SEQ. ID No. 2) genomic libraries. The promoter includes a region (nucleotides 3130 to 3350 of SEQ. ID No. 1 which affects selective gene expression in endothelial cells), and a region (nucleotides 2270 to 2840 of SEQ. ID No. 1) which affects selective gene expression in large vessel endothelial cells, as compared to expression in all endothelial cells. The EPCR promoter contains a thrombin responsive element, CCCACCCC (SEQ. ID No. 3), (murine, nucleotides 3007 to 3014 SEQ. ID No. 1 and human, nucleotides 2722 to 2729 SEQ. ID No. 2). The EPCR also contains a serum response element (nucleotides 2990 to 3061 of SEQ. ID No. 1). The regulatory sequences present in the EPCR promoter can be used for thrombin or serum controlled recombinant gene expression specific to either all endothelial cells or primarily endothelial cells of large vessels. Therapeutic strategies include the use of the minimal promoter for expression of therapeutic agents during times of increased thrombin/platelet activation or regional trauma in all endothelial cells or the use of the large vessel specific promoter for regional specific expression in the endothelial cells of large vessels for use in delivery.
Patent AU-770652-B2 (AU)
Title: An integrin heterodimer and an alpha subunit thereof
Inventor: GULLBERG DONALD
IPC: C12Q1/68
Filed: 2000-05-31
Granted: 2004-02-26
Abstract: A recombinant or isolated integrin heterodimer comprising a novel subunit α11 in association with a subunit β is described. The integrin or the subunit α11 can be used as marker or target of all types of cells. The integrin or subunit α11 thereof can be used as marker or target in different physiological or therapeutic methods. They can also be used as active ingredients in pharmaceutical compositions and vaccines.
Patent AU-631638-B2 (AU)
Title: Anthracycline conjugates having a novel linker and methods for their production
IPC: A61K31/70
Filed: 1990-05-16
Granted: 1992-12-03
Abstract: The present invention relates to novel conjugates, methods for their production, pharmaceutical compositions and methods for delivering cytotoxic anthracyclines to a selected population of cells desired to be eliminated. The anthracycline conjugates comprise at least one anthracycline molecule linked to a ligand that is reactive with a cell population to be eliminated, the anthracycline having a keto group at the C-13 position, and being attached to the ligand via a linker arm and being bound to that linker arm via an acid-sensitive acylhydrazone bond at the 13-keto position of the anthracycline. The conjugates of the invention are therefore useful in antibody- or ligand-mediated drug delivery systems for the preferential killing of a selected cell population in the treatment of diseases such as cancers and other tumors, non-cytocidal viral or other pathogenic infections, and autoimmune disorders.
Patent AU-642879-B2 (AU)
Title: Glycosylated haemoglobin assay
Inventor: SUNDREHAGEN ERLING
IPC: G01N33/00
Filed: 1990-05-11
Granted: 1993-11-04
Abstract: PCT No. PCT/EP90/00820 Sec. 371 Date Nov. 1, 1990 Sec. 102(e) Date Nov. 1, 1990 PCT Filed May 11, 1990 PCT Pub. No. WO90/13818 PCT Pub. Date Nov. 15, 1990.A method of assessing glycosylated haemoglobin in a sample, wherein the method comprises the steps of (a) contacting the sample with signal-forming molecules comprising a conjugate of one or more dihydroxyboryl residues or salts thereof, linked to a signal-forming label; (b) separating by selective precipitation from a homogenous solution, glycosylated and non-glycosylated haemoglobin and any molecules bound thereto, from the reaction mixture of step (a) above; and (c) assessing signal-forming molecules selected from the group consisting of signal-forming molecules which have bound to the separated haemoglobin, and non-haemoglobin bound signal-forming molecules. Steps (a) and (b) may be performed simultaneously or sequentially. The sample may optionally be haemolyzed to liberate any cell bound haemoglobin. The invention also comprises an analytical test kit for use in accordance with the method of the invention. The new assay of the invention is particularly useful for the in vitro diagnosis and monitoring of diabetes mellitus.
Patent AU-594333-B2 (AU)
Title: Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav
Inventor: WATANABE SUSAN MITSUE
IPC: C12N1/00
Filed: 1986-04-07
Granted: 1990-03-08
Abstract: Immunologically reactive gag proteins of LAV are expressed in bacterial cells. The gag proteins are encoded by a recombinant plasmid containing procaryotic trancriptional and translational signals for expression, followed downstream by a DNA sequence comprising a portion of the gag region of LAV. Preferred signals for expression are selected from an inducible and/or suppressible operon, such as the trp operon. The gag proteins are isolated from the bacterial host and are utilized in diagnostic assays which detect the presence of LAV antigens or antibodies immunologically reactive with LAV. Further, the proteins produced by the method disclosed may be used as a vaccine against infection by the causitive virus for acquired immune deficiency syndrome.
Patent AU-640935-B2 (AU)
Title: Method and apparatus for the treatment of mineral fibre or glass waste for the recovery thereof
Inventor: DEBLOCK ROGER
IPC: C03C25/00
Filed: 1990-06-26
Granted: 1993-09-09
Abstract: The process for the treatment of waste comprising a substrate of glass or of inorganic fibres in combination with organic matter consists in introducing the waste (7) on a conveyor (4) into the enclosure (1) of a furnace, in subjecting it to a gas heated to a temperature below the softening temperature of the substrate of the waste and consisting of inert gas and of 0 to 10% by volume of oxygen to pyrolyse the organic matter and in recovering the substrate from the waste. 
<??>Application to the recovery of vitreous matter forming the substrate of the waste with a view to its being recycled into a glass- melting furnace. 
<IMAGE>
Patent AU-640938-B2 (AU)
Title: Melamine-containing photoresists of improved sensitivity
Inventor: GRAZIANO KAREN ANN
IPC: G03F7/038
Filed: 1990-07-04
Granted: 1993-09-09
Abstract: Melamine-containing photoresists are disclosed that display increased sensitivity, measured as lithographic potential, when compared to known photoresists that contain melamine resin as a crosslinker. The melamine resin in these photoresists contains a higher percent, by weight, of monomeric hexamethoxymethylmelamine than in known resists.
Patent AU-696959-B2 (AU)
Title: Process for the development of endophyte-infected plants
Inventor: BREDE A DOUGLAS
IPC: A01H5/12
Filed: 1996-06-05
Granted: 1998-09-24
Abstract: Beneficial endophytes which live within certain plants are known to provide desirable, cost-effective biological insect control. Many naturally occurring grasses host symbiotic endophytic fungi. However, beneficial endophytes have never been found in several species of turf grass, including species of bentgrasses and Kentucky bluegrasses, two commercially important turf grasses which are used extensively on golf courses and for lawn turfs. The invention of this application relates to new methods of inoculating plant tissues which allow the development of endophyte-enhanced varieties of turfgrasses, and to the turf grass varieties produced using the methods.